Showing 1 - 4 results of 4 for search '"Derived neutrophil-to-lymphocyte ratio"', query time: 0.05s Refine Results
  1. 1
    Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

    Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metas... by Miguel Caballero-Borrego, Aida Piedra, Óscar Gallego, Antonio López-Pousa, Paola Castillo, Pilar Navarrete, Alba Prat, Juan J. Grau

    Published 2024-11-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs

    Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs by Chengyang Yu, Hao Jiang, Liezhi Wang, Zufu Jiang, Chong Jin

    Published 2025-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Day 3 neutrophil-to-lymphocyte ratio and its derived indices predict 90-day poor outcomes following mechanical thrombectomy in acute ischemic stroke patients

    Day 3 neutrophil-to-lymphocyte ratio and its derived indices predict 90-day poor outcomes following mechanical thrombectomy in acute ischemic stroke patients by Weiwei Gao, Arslan Annadurdyyev, Lingfeng Yu, Rong Huang, Bin Liu, Yixiong Lin, Huaiyi Li, Renjing Zhu

    Published 2024-12-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Comparison of Prognostic Values of Seven Immune Indexes in Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab: How Effective Can They Be Regarding Our Treatment Decisions?

    Comparison of Prognostic Values of Seven Immune Indexes in Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab: How Effective Can They Be Regarding Our Treatment Decisions? by Arife Ulas, Beyza Temel, Fahriye Tugba Kos

    Published 2024-11-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: